Given the current focus on developing treatments for Alzheimer’s disease, we expect the B6.CR2CR1 model to be a key resource to advance our understanding of how CR1 risk alleles contribute to disease susceptibility. The gene discussed is CR1; the disease is early-onset autosomal dominant Alzheimer disease.